Annual CAPEX
$726.30 K
+$427.40 K+142.99%
01 December 2023
Summary:
COSCIENS Biopharma annual capital expenditures is currently $726.30 thousand, with the most recent change of +$427.40 thousand (+142.99%) on 01 December 2023. During the last 3 years, it has risen by +$160.90 thousand (+28.46%).CSCI CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly CAPEX
$131.00 K
-$26.60 K-16.88%
01 September 2024
Summary:
COSCIENS Biopharma quarterly capital expenditures is currently $131.00 thousand, with the most recent change of -$26.60 thousand (-16.88%) on 01 September 2024. Over the past year, it has dropped by -$473.30 thousand (-78.32%).CSCI Quarterly CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM CAPEX
$1.46 M
+$81.00 K+5.89%
01 September 2024
Summary:
COSCIENS Biopharma TTM capital expenditures is currently $1.46 million, with the most recent change of +$81.00 thousand (+5.89%) on 01 September 2024. Over the past year, it has increased by +$717.00 thousand (+96.98%).CSCI TTM CAPEX Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CSCI CAPEX Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | - | -78.3% | +97.0% |
| 3 y3 years | +28.5% | -14.3% | +161.9% |
| 5 y5 years | +185.1% | +3993.8% | +462.3% |
CSCI CAPEX High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3 years | ||||||
| 5 y | 5 years | ||||||
| alltime | all time | -94.3% | -99.3% | -92.2% |
COSCIENS Biopharma CAPEX History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $131.00 K(-16.9%) | $1.46 M(+5.9%) |
| June 2024 | - | $157.60 K(-72.0%) | $1.38 M(+8.2%) |
| Mar 2024 | - | $563.40 K(-6.8%) | $1.27 M(+72.0%) |
| Dec 2023 | $726.30 K(+143.0%) | $604.30 K(+1108.6%) | $739.30 K(+304.7%) |
| Sept 2023 | - | $50.00 K(-7.2%) | $182.70 K(-1.3%) |
| June 2023 | - | $53.90 K(+73.3%) | $185.20 K(+7.2%) |
| Mar 2023 | - | $31.10 K(-34.8%) | $172.70 K(-39.7%) |
| Dec 2022 | $298.90 K(-47.1%) | $47.70 K(-9.1%) | $286.50 K(-26.8%) |
| Sept 2022 | - | $52.50 K(+26.8%) | $391.60 K(-20.0%) |
| June 2022 | - | $41.40 K(-71.4%) | $489.70 K(+0.9%) |
| Mar 2022 | - | $144.90 K(-5.2%) | $485.10 K(-12.8%) |
| Dec 2021 | $565.40 K(+22.4%) | $152.80 K(+1.5%) | $556.10 K(-23.0%) |
| Sept 2021 | - | $150.60 K(+309.2%) | $722.50 K(+7.3%) |
| June 2021 | - | $36.80 K(-83.0%) | $673.50 K(-2.0%) |
| Mar 2021 | - | $215.90 K(-32.4%) | $687.30 K(+41.5%) |
| Dec 2020 | $462.00 K(+81.3%) | $319.20 K(+214.2%) | $485.60 K(+186.3%) |
| Sept 2020 | - | $101.60 K(+100.8%) | $169.60 K(-35.3%) |
| June 2020 | - | $50.60 K(+256.3%) | $262.20 K(+17.9%) |
| Mar 2020 | - | $14.20 K(+343.8%) | $222.30 K(-14.2%) |
| Dec 2019 | $254.80 K(-73.7%) | $3200.00(-98.4%) | $259.00 K(-31.2%) |
| Sept 2019 | - | $194.20 K(+1715.0%) | $376.50 K(-10.3%) |
| June 2019 | - | $10.70 K(-79.0%) | $419.90 K(-41.5%) |
| Mar 2019 | - | $50.90 K(-57.8%) | $717.70 K(-22.1%) |
| Dec 2018 | $968.50 K(-68.8%) | $120.70 K(-49.2%) | $921.50 K(-45.5%) |
| Sept 2018 | - | $237.60 K(-23.0%) | $1.69 M(-12.9%) |
| June 2018 | - | $308.50 K(+21.1%) | $1.94 M(-24.1%) |
| Mar 2018 | - | $254.70 K(-71.3%) | $2.55 M(-20.1%) |
| Dec 2017 | $3.10 M(-17.6%) | $888.50 K(+82.4%) | $3.20 M(+16.2%) |
| Sept 2017 | - | $487.20 K(-47.2%) | $2.75 M(-7.5%) |
| June 2017 | - | $923.30 K(+3.0%) | $2.98 M(-12.5%) |
| Mar 2017 | - | $896.70 K(+102.1%) | $3.40 M(-8.2%) |
| Dec 2016 | $3.76 M(+14.1%) | $443.80 K(-37.6%) | $3.71 M(-15.3%) |
| Sept 2016 | - | $711.30 K(-47.3%) | $4.37 M(-5.9%) |
| June 2016 | - | $1.35 M(+12.5%) | $4.64 M(+20.0%) |
| Mar 2016 | - | $1.20 M(+8.1%) | $3.87 M(+27.7%) |
| Dec 2015 | $3.30 M(-21.3%) | $1.11 M(+12.9%) | $3.03 M(+18.9%) |
| Sept 2015 | - | $983.60 K(+70.6%) | $2.55 M(+26.6%) |
| June 2015 | - | $576.60 K(+60.2%) | $2.01 M(-31.8%) |
| Mar 2015 | - | $359.90 K(-42.8%) | $2.95 M(-25.8%) |
| Dec 2014 | $4.18 M(+87.1%) | $629.10 K(+40.3%) | $3.98 M(-16.9%) |
| Sept 2014 | - | $448.40 K(-70.5%) | $4.79 M(+0.8%) |
| June 2014 | - | $1.52 M(+9.6%) | $4.75 M(+43.6%) |
| Mar 2014 | - | $1.38 M(-3.6%) | $3.31 M(+53.0%) |
| Dec 2013 | $2.24 M(+816.8%) | $1.44 M(+248.7%) | $2.16 M(+173.2%) |
| Sept 2013 | - | $411.90 K(+440.6%) | $791.80 K(+91.5%) |
| June 2013 | - | $76.20 K(-68.1%) | $413.40 K(+8.1%) |
| Mar 2013 | - | $238.60 K(+266.5%) | $382.60 K(+56.0%) |
| Dec 2012 | $244.00 K(+91.7%) | $65.10 K(+94.3%) | $245.20 K(+12.1%) |
| Sept 2012 | - | $33.50 K(-26.2%) | $218.80 K(+2.5%) |
| June 2012 | - | $45.40 K(-55.1%) | $213.50 K(+19.6%) |
| Mar 2012 | - | $101.20 K(+161.5%) | $178.50 K(+44.8%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2011 | $127.30 K(+44.2%) | $38.70 K(+37.2%) | $123.30 K(-12.0%) |
| Sept 2011 | - | $28.20 K(+171.2%) | $140.10 K(-1.7%) |
| June 2011 | - | $10.40 K(-77.4%) | $142.50 K(+8.0%) |
| Mar 2011 | - | $46.00 K(-17.1%) | $131.90 K(+44.9%) |
| Dec 2010 | $88.30 K(+92.4%) | $55.50 K(+81.4%) | $91.00 K(+105.0%) |
| Sept 2010 | - | $30.60 K(<-9900.0%) | $44.40 K(+11.8%) |
| June 2010 | - | -$200.00(-103.9%) | $39.70 K(-19.3%) |
| Mar 2010 | - | $5100.00(-42.7%) | $49.20 K(-1.2%) |
| Dec 2009 | $45.90 K(-84.1%) | $8900.00(-65.6%) | $49.80 K(+311.6%) |
| Sept 2009 | - | $25.90 K(+178.5%) | $12.10 K(-57.8%) |
| June 2009 | - | $9300.00(+63.2%) | $28.70 K(-54.7%) |
| Mar 2009 | - | $5700.00(-119.8%) | $63.40 K(-74.8%) |
| Dec 2008 | $288.10 K(-80.8%) | -$28.80 K(-167.8%) | $251.40 K(-53.8%) |
| Sept 2008 | - | $42.50 K(-3.4%) | $544.50 K(-55.4%) |
| June 2008 | - | $44.00 K(-77.3%) | $1.22 M(-32.1%) |
| Mar 2008 | - | $193.70 K(-26.7%) | $1.80 M(+11.1%) |
| Dec 2007 | $1.50 M(+2084.7%) | $264.30 K(-63.2%) | $1.62 M(+25.8%) |
| Sept 2007 | - | $718.80 K(+15.7%) | $1.29 M(+88.1%) |
| June 2007 | - | $621.30 K(+4402.2%) | $683.80 K(+855.0%) |
| Mar 2007 | - | $13.80 K(-120.4%) | $71.60 K(+7.2%) |
| Dec 2006 | $68.60 K(-31.4%) | -$67.50 K(-158.1%) | $66.80 K(-61.9%) |
| Sept 2006 | - | $116.20 K(+1176.9%) | $175.10 K(+146.3%) |
| June 2006 | - | $9100.00(+1.1%) | $71.10 K(-3.0%) |
| Mar 2006 | - | $9000.00(-77.9%) | $73.30 K(-29.7%) |
| Dec 2005 | $100.00 K(-72.8%) | $40.80 K(+234.4%) | $104.20 K(-48.1%) |
| Sept 2005 | - | $12.20 K(+8.0%) | $200.90 K(-50.3%) |
| June 2005 | - | $11.30 K(-71.7%) | $404.60 K(-4.6%) |
| Mar 2005 | - | $39.90 K(-71.0%) | $424.10 K(+6.8%) |
| Dec 2004 | $367.40 K(+284.3%) | $137.50 K(-36.3%) | $397.00 K(+47.0%) |
| Sept 2004 | - | $215.90 K(+601.0%) | $270.10 K(+396.5%) |
| June 2004 | - | $30.80 K(+140.6%) | $54.40 K(+54.1%) |
| Mar 2004 | - | $12.80 K(+20.8%) | $35.30 K(-65.7%) |
| Dec 2003 | $95.60 K(-23.6%) | $10.60 K(+5200.0%) | $103.00 K(-52.1%) |
| Sept 2003 | - | $200.00(-98.3%) | $214.90 K(+0.1%) |
| June 2003 | - | $11.70 K(-85.5%) | $214.60 K(+4.5%) |
| Mar 2003 | - | $80.50 K(-34.3%) | $205.30 K(+64.5%) |
| Dec 2002 | $125.10 K(+1590.5%) | $122.50 K(<-9900.0%) | $124.80 K(+5326.1%) |
| Sept 2002 | - | -$100.00(-104.2%) | $2300.00(-4.2%) |
| June 2002 | - | $2400.00(-76.7%) | $2400.00(-89.1%) |
| Dec 2001 | $7400.00(-66.8%) | - | - |
| Dec 2000 | $22.30 K(-66.9%) | $10.30 K(-12.0%) | $22.00 K(+73.2%) |
| Sept 2000 | - | $11.70 K(+1070.0%) | $12.70 K(-81.6%) |
| Dec 1999 | $67.30 K(-50.1%) | $1000.00(+233.3%) | $69.10 K(-153.4%) |
| Sept 1999 | - | $300.00(-99.6%) | -$129.50 K(-165.5%) |
| June 1999 | - | $67.80 K(-134.3%) | $197.70 K(+52.2%) |
| Dec 1998 | $135.00 K(-98.9%) | -$197.60 K(-160.3%) | $129.90 K(-216.4%) |
| Sept 1998 | - | $327.50 K(-174.6%) | -$111.60 K(-100.9%) |
| Dec 1997 | $12.64 M(+178.1%) | -$439.10 K(-309.1%) | $12.23 M(-3.5%) |
| Sept 1997 | - | $210.00 K(-103.4%) | $12.67 M(+1.7%) |
| June 1997 | - | -$6.24 M(-133.4%) | $12.46 M(-33.4%) |
| Mar 1997 | - | $18.70 M | $18.70 M |
| Dec 1996 | $4.55 M | - | - |
FAQ
- What is COSCIENS Biopharma annual capital expenditures?
- What is the all time high annual CAPEX for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly capital expenditures?
- What is the all time high quarterly CAPEX for COSCIENS Biopharma?
- What is COSCIENS Biopharma quarterly CAPEX year-on-year change?
- What is COSCIENS Biopharma TTM capital expenditures?
- What is the all time high TTM CAPEX for COSCIENS Biopharma?
- What is COSCIENS Biopharma TTM CAPEX year-on-year change?
What is COSCIENS Biopharma annual capital expenditures?
The current annual CAPEX of CSCI is $726.30 K
What is the all time high annual CAPEX for COSCIENS Biopharma?
COSCIENS Biopharma all-time high annual capital expenditures is $12.64 M
What is COSCIENS Biopharma quarterly capital expenditures?
The current quarterly CAPEX of CSCI is $131.00 K
What is the all time high quarterly CAPEX for COSCIENS Biopharma?
COSCIENS Biopharma all-time high quarterly capital expenditures is $18.70 M
What is COSCIENS Biopharma quarterly CAPEX year-on-year change?
Over the past year, CSCI quarterly capital expenditures has changed by -$473.30 K (-78.32%)
What is COSCIENS Biopharma TTM capital expenditures?
The current TTM CAPEX of CSCI is $1.46 M
What is the all time high TTM CAPEX for COSCIENS Biopharma?
COSCIENS Biopharma all-time high TTM capital expenditures is $18.70 M
What is COSCIENS Biopharma TTM CAPEX year-on-year change?
Over the past year, CSCI TTM capital expenditures has changed by +$717.00 K (+96.98%)